The results illustrated that the anti-PD-1 treatment alone only slightly suppressed tumor growth (Fig. 8b–e), possibly due to the limited T cell infiltration in the immunosuppressive TME of B16F10 melanoma. Here, PDCD1 is linked to neoplasm.